Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Transplantation for myelodysplastic syndromes 2013.

    ... RECENT FINDINGS: The newly published modified International Prognostic Scoring System (IPSS-R), developed for nontransplanted patients, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Myelodysplastic syndromes

    ... of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System ), treatment options according to ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Impact of comorbidities by ACE-27 in the Revised-IPSS for patients with myelodysplastic syndromes

    ... patients were reclassified according to the Revised- International Prognostic Scoring System (IPSS-R). Methods: The medical records of 600 ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

    ... International Prognostic Scoring System -defined Low- or Intermediate-1-risk (lower-risk) ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes

    ... failure. All intermediate-2 or high-risk MDS patients by International Prognostic Scoring System and only those low/intermediate-1 patients with ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

    ... MDS patients, especially those classified as International Prognostic Scoring System (IPSS) Low or Intermediate-1 (Low/Int-1). ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    ... 3, MDS-004 study to evaluate outcomes in patients with International Prognostic Scoring System (IPSS)-defined Low-/Intermediate (Int)-1-risk ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    ... leukaemia (AML) progression in 215 patients with International Prognostic Scoring System (IPSS) low or intermediate-1 risk and del(5q). ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. How we treat higher-risk myelodysplastic syndromes

    ... higher risk group categories in the original or revised International Prognostic Scoring System (IPSS). Survival for these patients is dismal, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

    ... (J Clin Oncol, 25, 2007, 4246). Cytogenetic analysis and International Prognostic Scoring System (IPSS) risk assessment were performed ...

    Research Article last updated 07/20/2018 - 5:15pm.